INS and Huntington disease: Several preclinical studies in HD mouse models confirm dysregulated systemic metabolism and associated changes in glucose and insulin homeostasis, which were described in people with HD (Lalić et al., 2008 [45]), by demonstrating increased circulating levels of these molecules [44,111,112], as summarized in Table 3.